BREAKING
Legence Corp. (LGN) Reports Q4 Earnings 14 minutes ago Autolus Therapeutics plc (AUTL) Reports Q4 Earnings 19 minutes ago LM Funding America, Inc. (LMFA) Reports Q4 Earnings 25 minutes ago 51Talk Online Education Group (COE) Reports Q4 Earnings 26 minutes ago Super League Enterprise, Inc. (SLE) Reports Q4 Earnings 44 minutes ago Arcadia Biosciences 2025 Financial Results 1 hour ago Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings 1 hour ago X Financial (XYF) Q4 2025 Earnings Recap 1 hour ago SBC Medical Group Holdings Incorporated (SBC) Beats Q4 EPS Estimates by 16.7% 1 hour ago Vivani Medical 2025 Financial Results Analysis 2 hours ago Legence Corp. (LGN) Reports Q4 Earnings 14 minutes ago Autolus Therapeutics plc (AUTL) Reports Q4 Earnings 19 minutes ago LM Funding America, Inc. (LMFA) Reports Q4 Earnings 25 minutes ago 51Talk Online Education Group (COE) Reports Q4 Earnings 26 minutes ago Super League Enterprise, Inc. (SLE) Reports Q4 Earnings 44 minutes ago Arcadia Biosciences 2025 Financial Results 1 hour ago Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings 1 hour ago X Financial (XYF) Q4 2025 Earnings Recap 1 hour ago SBC Medical Group Holdings Incorporated (SBC) Beats Q4 EPS Estimates by 16.7% 1 hour ago Vivani Medical 2025 Financial Results Analysis 2 hours ago
ADVERTISEMENT
Breaking News

Legence Corp. (LGN) Reports Q4 Earnings

Legence Corp. (LGN) reported Q4 2026 basic and diluted earnings of -$0.55 per share.

March 27, 2026 1 min read

Legence Corp. (LGN) reported Q4 2026 basic and diluted earnings of -$0.55 per share.

LGNLGN|EPS -$0.55|Rev $737.6M|Net Loss $32.7M

Legence Corp. (LGN) reported Q4 2025 basic and diluted earnings of -$0.55 per share. The company generated $737.6M in revenue for the quarter. Revenue of $737.6M was up 34.6% year-over-year.

Legence Corp. is a Engineering & Construction company. Total Backlog and Awarded Contracts was $3.7 billion for the quarter. Installation & Maintenance led with $565.1M in revenue, up 44.4% year-over-year. Total Backlog and Awarded Contracts increased 49% year-over-year. Bottom line showed a net loss of $32.7M.

Revenue guidance for the next quarter was set at $925.0M to $950.0M. Wall Street consensus stands at 17 buy, 2 hold, 0 sell. EPS was up 3.5% from -$0.57 in Q4 2024. Revenue was up 34.6% from $548.2M in Q4 2024.

A detailed analysis of Legence Corp.’s quarter follows shortly on AlphaStreet.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

ADVERTISEMENT